941
Views
5
CrossRef citations to date
0
Altmetric
Research Papers

Factors affecting the seroconversion rate of 12-month-old babies after the first injection of measles vaccine in the southeast of Iran

, &
Pages 3118-3124 | Received 15 Apr 2016, Accepted 12 Jul 2016, Published online: 25 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shahrokh Izadi, Masoome Arabsalmani, Mahdi Mohammadi, Seyed Mehdi Tabatabaei & Ali-Akbar Haghdoost. (2018) Reiteration of the elimination status of measles in the southeast of Iran, 2015. Human Vaccines & Immunotherapeutics 14:12, pages 2957-2963.
Read now
Shahrokh Izadi, Seyed Mohsen Zahraei & Talat Mokhtari-Azad. (2018) Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran. Human Vaccines & Immunotherapeutics 14:6, pages 1412-1416.
Read now

Articles from other publishers (3)

Hana Saffar, Sayed Jaber Mousavi, Hiva Saffar, Mohammad-Reza Parsaei, Gholam-Reza Ghorbani & Mohammad Jafar Saffar. (2022) Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age. BMC Immunology 23:1.
Crossref
Hana Saffar, Maryam Khalifeloo, Mohammad-Jafar Saffar, Alireza Abdollahi, Mohammad-Reza Parsaei, Gholam-Reza Ghorbani, Samaneh Salarvand & Mohsen Aarabi. (2021) Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran. BMC Infectious Diseases 21:1.
Crossref
Shahrokh Izadi, Seyed Mohsen Zahraei, Masoud Salehi, Mahdi Mohammadi, Seyed Mehdi Tabatabaei & Talat Mokhtari-Azad. (2018) Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8–12 months: A randomized clinical trial. Vaccine 36:5, pages 631-636.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.